「rate of administration」に関連した英語例文の一覧と使い方 - Weblio英語例文検索

To provide a gasket for a syringe offering less deterioration in drug strength during its storage time, and high accuracy of flow rate when used for drug administration.例文帳に追加

保管中の薬剤力価の低下が少なく、また、使用時においては高い流量精度で投与可能なシリンジ用ガスケットを提供する。 - 特許庁

The president of the Supreme Patent and Trademark Chamber as the head of that authority shall be entitled to annual special-duty pay at the rate of 250 percent and the vice-president at the rate of 125 percent of the monthly salary of a federal civil servant in active service in salary step 1 of service grade IX of the General Administration. 例文帳に追加

特許商標最高審判所の長である所長は，連邦常勤公務員一般行政職第IX級第1号俸の月額俸給の250パーセント，また，副所長は前記の125パーセントに当たる年間特別職務給を受け取る権利を有する。 - 特許庁

The dissolving rate of the solvate's active ingredient in the gastric juice of a relevant patient is curatively important because the active ingredient subject to oral administration imparts an upper limit to the rate enabling the active ingredient to be delivered to the patient's blood stream.例文帳に追加

患者の胃液における活性成分の溶解速度は、経口投与される活性成分が患者の血流に達することができる速度に対して上限を付与するので、治療重要性を有する。 - 特許庁

In the process of contracting out the myoden administration to tato fumyo by kokuga, the conditions, such as the rate and the item of taxation imposed on each myoden, became varied based on the situation in each area. 例文帳に追加

国衙が名田経営を田堵負名に請け負わせていく中で、地域の実情に合わせて各名田ごとに税率や税目などに差異も生まれていった。 - Wikipedia日英京都関連文書対訳コーパス

The formulation is suitable for ranolazine administration of twice a day and useful for controlling the rate of dissolution of ranolazine and to maintain the human plasma ranolazine level at 850-4,000 ng/mL.例文帳に追加

本製剤は、１日２回のラノラジン投与に適し、ラノラジンの溶解速度を制御してヒト血漿中ラノラジンレベルを８５０〜４０００ｎｇ／ｍＬに維持するために有用である。 - 特許庁

The conjugate exhibits an excellent absorption rate and biocompatibility in biological mucous membranes, particularly in mucous membranes of the alimentary canal (especially the gastrointestinal tract), in vivo degradability, and superior bioavailability even with oral administration, thus enables treatment of diseases via oral administration of a drug.例文帳に追加

本発明のコンジュゲートは、生体粘膜、特に、消化管(特に胃腸管)にある粘膜において吸収率及び生体的合成に優れており、且つ体内で分解されて、また、経口投与時も生体利用率に優れ、薬剤の経口投与による疾病の治療を可能にする。 - 特許庁

To provide a controlled release nanoparticulate composition comprising a nanoparticulate agonist to be administered, and a rate-controlling polymer which functions to prolong the release of the agonist following administration.例文帳に追加

投与されるべきナノ粒子状作用薬と投与後その作用薬の放出を延長するように働く速度制御性ポリマーを含む徐放性ナノ粒子組成物の提供。 - 特許庁

The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the dissolution rate of ranolazine, and to maintain human plasma ranolazine levels between 550 and 7,500 ng base/mL.例文帳に追加

該製剤は、１日２回のラノラジン投与に適しており、ラノラジンの溶解速度の調節、並びに、５５０から７５００ｎｇ塩基／ｍＬの血漿中ヒトラノラジンレベルを維持するのに有用である。 - 特許庁

Funds to the amount of 25 percent of the annual salary finances rate according to the budget of the Patent Office shall be allotted for extra material stimulation of the administration personnel, such funds being included in the State Budget Law of the Republic of Bulgaria for the respective year. 例文帳に追加

特許庁予算に従う年間給与資金の25パーセントの額までの資金は，行政職人事の臨時人材強化策として割り当てられ，当該資金は，各年につきブルガリア共和国の国家予算法に含まれている。 - 特許庁

To efficiently perform the comprehensive administration of the working assets and procured liability of a joint financing of yen basis fixed interest rate by private banks performed jointly with international corporate banks on export credit.例文帳に追加

国際協力銀行との輸出金融に協調して行う、民間銀行の円建固定金利の協調融資について、この協調融資の運用資産と調達負債の総合的な管理を効率よく行う。 - 特許庁

To provide a container for powder and particle that can enhance the space efficiency and operating rate of a metering system, facilitate administration of residue for every batch, and cope with a wide variety of metering without a fear of mixing foreign matter, without producing waste.例文帳に追加

計量システムのスペース効率や稼働率を高め、ロット毎の残量管理を簡易にし、少スペースで異品種混入のおそれや廃棄物を生じることなく多品種計量に対処することができる紛粒体コンテナを提供する。 - 特許庁

To accurately monitor interruption of administration caused by the shortage of liquid or plugging of a conduit and whether the flow rate of the liquid is in a normal range or not when the liquid is administered to a patient without complicating the structure of a monitoring device.例文帳に追加

監視装置の構造の複雑化を招くことなく、液体の患者への投与時において、液切れ、導管の閉塞等による投与の中断、及び液体の流量が正常範囲にあるか否かを的確に得ることができるようにする。 - 特許庁

Since the tolerance for determining the ballot as the valid vote can be changed, the rate of becoming questionable votes can be freely set corresponding to the different operation of an election administration commission and a local government according to an election, and a vote counting time can be shortened.例文帳に追加

有効票として判定する許容範囲を変更可能とするため、選挙によって選挙管理委員会や自治体での運用が異なるのに対応して、疑問票となる割合を自由に設定でき、開票時間の短縮が可能となる。 - 特許庁

The food containing royal jelly has a suitable mode for giving ≤11 g/day royal jelly oral ingestion rate based on raw royal jelly, and the medicine is composed mainly of royal jelly and has hypotensive effect and ≤11 g/day royal jelly oral administration rate based on raw royal jelly.例文帳に追加

ローヤルゼリーの１日当りの経口摂取量が生ローヤルゼリー換算で１１ｇまでであるのに好適な形態を有するローヤルゼリーを含有する食品、および、ローヤルゼリーを主成分とし、血圧降下作用を有する薬剤であって、ローヤルゼリーの１日当りの経口投与量が生ローヤルゼリー換算で１１ｇまでである薬剤。 - 特許庁

To provide a particulate pharmaceutical composition for oral administration capable of suppressing or decreasing the amount of initial drug dissolution and maintaining the subsequent rapid drug release and further capable of decreasing a change in drug dissolution rate after compression molding, and also to provide a disintegrating tablet in a buccal cavity which contains the pharmaceutical composition.例文帳に追加

初期薬物溶出量を抑制または低減し、その後の速やかな薬物放出を維持しつつ、圧縮成形後も薬物溶出速度の変化を低減可能な、経口投与用粒子状医薬組成物と、該医薬組成物を含有してなる口腔内崩壊錠を提供する。 - 特許庁

To provide a feeding set and an enteral feeding pump having a safety interlock device for determining that an administration feeding set to deliver a supply of nutrient fluid to a patient by a flow rate control device is surely mounted on an enteral feeding pump.例文帳に追加

流量制御装置により栄養液を患者へ送る投与供給セットが経腸供給ポンプ上に確実に装着されていることを判定する安全連動装置を有する供給セット及び経腸供給ポンプを提供する。 - 特許庁

This controlled release oxycodone preparation for administration to human patients comprises (a) an analgesically effective amount of a spheroid comprising an oxycondone salt and a spheroidizing agent and (b) a film coating controlling the release of the oxycodone salt at a controlled rate in an aqueous medium.例文帳に追加

ヒト患者に投与するための制御放出オキシコドン剤であって、（ａ）オキシコドン塩及びスフェロイド形成剤を含む、鎮痛目的に有効な量のスフェロイドと、（ｂ）水性媒質中でのオキシコドン塩の放出を制御された速度にて制御するフィルムコーティング、を含む制御放出オキシコドン剤。 - 特許庁

To provide a sustained-release base material with controlled sustained-release properties, especially one for bioabsorbable medical formulations which controls the rapid initial release of effective-ingredient drugs after administration of a formulation and can release the drugs at a specified rate for a month.例文帳に追加

徐放性の制御された徐放性基材、とりわけ生体吸収性医薬製剤において、製剤投与後に有効成分である薬物の急激な初期放出が抑制され、かつ１ヶ月間定められた速度で薬物が放出されうる徐放性基材を提供することを課題とする。 - 特許庁

To provide a bioabsorbable release-sustaining pharmaceutical formulation using a biodegradable release-sustaining base material which can prevent an effective component drug from being released too rapidly just after administration of the formulation and then allow continued release of the drug for at least one month at a defined rate.例文帳に追加

医薬品製剤において、製剤投与後に有効成分である薬物の急激な初期放出が抑制され、かつ１ヶ月間定められた速度で薬物が放出される生体内分解性徐放性基材を用いた生体吸収性徐法性医薬製剤を提供することを課題とする。 - 特許庁

To prevent an accident such as sudden administration of a liquid drug due to a change in the flow rate made by others including a patient after the flow rate is set by a person responsible for flow adjustment of a liquid drug including a physician.例文帳に追加

コンピューターなどで液体の供給量を制御できる電動の輸液ポンプを使用せず、在宅医療などでも容易に使用できる液体供給具を使用する際に、医師などの薬液の流量の調節を行う者が一度流量を設定した後、患者を含めた他の者が流量の調節を変更することによる急激な薬液の投与などによる事故などを防ぐ。 - 特許庁

To be concrete, the test method is constituted of a process for administering a composition containing a high concentration of the lower alcohol to the skin model (process 1); a process for blowing air and drying an administered specimen (process 2); a process for cultivating the skin model after the administration (process 3); a process for evaluating a cell survival rate after the cultivation (process 4).例文帳に追加

具体的には、低級アルコールを高濃度に含む組成物を皮膚モデル上に投与する工程（工程１）、投与した検体を送風乾燥する工程（工程２）、投与後に皮膚モデルを培養する工程（工程３）、培養後の細胞生存率を評価する工程（工程４）より構成される。 - 特許庁

This method for administering the lipopeptide antibiotic at a dosage interval causing no skeletal muscle toxicity comprises a step of administering a therapeutically effective amount of the lipopeptide antibiotic at 3-75 mg/kg dosage to a human patient requiring the administration, and repeatedly administering the above antibiotic at a rate of once 24 hr to once a week.例文帳に追加

骨格筋毒性を生じない投薬間隔でリポペプチド抗生剤を投与するための方法であって、該方法は、治療上有効な量のリポペプチド抗生剤を３〜７５ｍｇ／ｋｇの用量で、その投与の必要なヒト患者に投与する工程であって、該リポペプチド抗生剤が、２４時間ごとに１回〜毎週１回反復投与される工程、を包含する、方法。 - 特許庁

The composition for releasing the pergolide to an individual requiring the pergolide therapy by the permeation through a body surface or membrane at a therapeutically effective rate contains pergolide mesylate in an amount effective for enabling successive release of the pergolide at least at 1 μg/cm^2×hr flow rate over the administration period to obtain the therapeutic plasma level of the pergolide, in a carrier.例文帳に追加

身体表面または膜を通る透過によってペルゴライド治療を必要とする個人に治療有効速度で身体表面または膜を通してペルゴライドを放出するための組成物であって、ペルゴライドの治療的血漿レベルを得るために、投与期間にわたり少なくとも１μｇ／ｃｍ^２・時間の流量によるペルゴライドの持続放出を可能にするのに有効な量のペルゴライドメシレートを担体中に含有する組成物である。 - 特許庁

To prepare a sustained- or controlled-release dosage form composed of a drug topically active in the gastrointestinal tract, wherein, following administration, controlled release from a first phase is ensured when an inert matrix shows the maximum release rate inside the logarithmic phase, namely a higher deviation from linear release.例文帳に追加

胃腸管で局所的に活性な薬剤から成る、徐放放出性、制御放出性投与製剤を調製する場合において、投与後の第一相、即ち、不活性マトリックスが対数期中最大の放出速度、つまり線形放出よりも高い偏差を有する時に、確実に放出を制御すること。 - 特許庁

There are provided the food having action to lower human serum cholesterol level, containing S-methyl cysteine sulfoxide (SMCS) and having a standard intake to intake 15-400 mg of SMCS, and a preventive or treating agent for human hypercholesterolemia containing SMCS and having an administration rate to administer 15-400 mg of SMCS.例文帳に追加

S-メチルシステインスルフォキシド(SMCS)を含有し、SMCSの摂取量が１５〜４００ｍｇとなるような標準摂取量であることを特徴とするヒト血清コレステロール値低下作用を有する食品、及びSMCSを含有し、SMCSの投与量が１５〜４００ｍｇとなるような投与量であることを特徴とするヒト高コレステロール血症予防又は治療剤。 - 特許庁

Such the sustained-release opioid formulation contains an effective amount of at least one retardant material to cause the opioid analgesic to be released at a such a rate as to provide an analgesic effect after oral administration to a human patient for at least about 24 hours, and is characterized by an absorption half-life of from 1 to about 8 hours.例文帳に追加

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。 - 特許庁

The sustained release opioid formulation contains an effective amount of at least one retardant material to cause the opioid analgesic to be released at such a rate as to provide an analgesic effect after oral administration to human patient for at least about 24 h, and is characterized by providing an absorption half-life of 1 to about 8 h.例文帳に追加

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。 - 特許庁

Yoshimune executed the Kyoho Reforms, one of the three major reforms during the Edo period, by the stabilization of the bakufu's financial revenue by means of a fixed tax rate and agemai (tribute rice) system, the development of new fields, the reform of bureaucratic systems including the tashidaka system (a wage system established by the Edo bakufu), the appointment of Tadasuke OOKA as a part of the reforms, improvement in the administration of justice by establishing the Kujikata Osadamegaki to accelerate judicial hearings, the establishment of measures against fires by installing Edo firefighters, and reforms to the bakufu's worsening finances. 例文帳に追加

定免法や上米の制による幕府財政収入の安定化、新田開発の推進、足高の制の制定等の官僚制度改革、そしてその一環ともいえる大岡忠相の登用、また訴訟のスピードアップのため公事方御定書を制定しての司法制度改革、江戸町火消しを設置しての火事対策、悪化した幕府財政の立て直しなどの改革を図り、江戸三大改革のひとつである享保の改革を行った。 - Wikipedia日英京都関連文書対訳コーパス

The method for administering a lipopeptide antibiotic with a dosage interval causing no skeletal muscle toxicity comprises a step of administering a therapeutically effective amount of the lipopeptide antibiotic at 3-75 mg/kg dosage to a human patient requiring the administration, wherein a step comprising repeatedly administering the lipopeptide antibiotic at a rate of once a 24 h to once a week is included.例文帳に追加

骨格筋毒性を生じない投薬間隔でリポペプチド抗生剤を投与するための方法であって、該方法は、治療上有効な量のリポペプチド抗生剤を３〜７５ｍｇ／ｋｇの用量で、その投与の必要なヒト患者に投与する工程であって、該リポペプチド抗生剤が、２４時間ごとに１回〜毎週１回反復投与される工程、を包含する、方法。 - 特許庁

This pharmaceutical composition is provided by containing (a) a hormone supplement composition for treating or preventing post menopausal diseases in the subject and (b) a sufficient amount of the folic acid for treating or preventing the diseases (i) suffering the subject directed with a high hormone supplement composition at a higher event rate than usual and (ii) capable of being treated or prevented by the administration of the folic acid.例文帳に追加

被験体における閉経期疾患を処置するかまたは予防するためのホルモン補充組成物及び（ｂ）（ｉ）ホルモン補充組成物が指示されている被験体を通常より高い発生率で悩まし、そして（ｉｉ）葉酸投与により処置できるかまたは予防できる疾患を処置するかまたは予防するために十分な量の葉酸を含んでなる製薬学的組成物。 - 特許庁

These sustained release opioid formulations include an effective amount of at least one retardant material to cause said opioid analgesic to be released at such a rate as to provide an analgesic effect after oral administration to a human patient for at least about 24 hours, and are characterized by providing an absorption half-life from 1 to about 8 hours.例文帳に追加

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。 - 特許庁

In my view, the FSA needs to take a rigorous approach against the Incubator Bank of Japan in connection with the progress and implementation of its business improvement plan. Moving on to the subject of his two years in office as an appointment of then-Minister for Financial Services Takenaka, I am sure that all of you know that the financial administration was then faced with many pressing issues, ranging from, for example, financial system stabilization and enhancement and promotion of a shift from saving to investment - as a matter of fact, it was a period that was filled with very challenging financial issues, including expediting a solution to the non-performing loan problem and reforming the securities market structure. At any rate, seeing as the recent turn of events, where someone with such experience got arrested for allegedly hindering an inspection later, is extremely regrettable and I am also aware that there is a high level of public attention to this matter, I am determined to exercise strict oversight, bearing firmly in mind the points I've just made. 例文帳に追加

当局としては同行の業務改善の状況とその実施について、この日本振興銀行、厳正に対処していく必要があると思いますし、また、竹中元金融担当大臣が任命された2年間でございますが、金融システムの安定化、強化、貯蓄から投資の流れの推進などの様々な課題が、当時金融行政としては喫緊の課題として山積していたということは皆さん方もご存じだと思うわけでございますが、不良債権問題（解決）の促進や証券市場の構造改革など金融行政上の非常に多難な問題が山積していた時代ではございましたが、いずれにいたしましても、こういった経験を有する者がその後の検査忌避により今回逮捕されたということは極めて遺憾であるし、また国民の関心も非常に高いものだと思っておりますので、しっかりその辺を踏まえて厳正に監督していく所存でございます。 - 金融庁

Article 24-2 The provisions of Chapter III, Section 1, Subsection 5 of the Financial Instruments and Exchange Act (Professional Investors) (excluding Article 34-2(6) to (8) inclusive (Cases Where Professional Investors Are Deemed to Be Customers Other Than Professional Investors) and Article 34-3(5) and (6) (Cases Where Juridical Persons Who Are Customers Other than Professional Investors Are Deemed to Be Professional Investors)), the provisions of Chapter III, Section 2, Subsection 1 of that Act (General Rules) (excluding Article 35 to Article 36-4 inclusive (Scope of Business of Persons Who Engage in Type I Financial Instruments Business or Investment Management Business; Scope of Additional Business of Persons Who Only Engage in Type II Financial Instruments Business or Investment Advisory and Agency Business; Duty of Good Faith to Customers; Posting of Signs; Prohibition on Name Lending; Prohibition on Administration of Bonds, etc.), Article 37(1)(ii) (Regulations on Advertising, etc.), Article 37-2 (Obligation to Clarify in Advance), Article 37-3(1)(ii) to (iv) inclusive and (vi) and 37-3(3) (Delivery of Documents Prior to the Conclusion of a Contract), Article 37-4 (Delivery of Documents upon Conclusion of a Contract, etc.), Article 37-5 (Delivery of Documents Pertaining to Receipt of Security Deposits), Article 38(i) and (ii) and Article 38-2 (Prohibited Acts), Article 39(1), Article 39(2)(ii), Article 39(3) and (5) (Prohibition of Compensation of Loss, etc.), Article 40(i) (Rule of Suitability), and Article 40-2 to Article 40-5 inclusive (Best Execution Policy; Prohibition of Sales and Purchases, etc. where Separate Management Is Not Maintained; Restriction on Sales, etc. of Securities to Professional Investors; Obligation to Provide Professional Investors with Information Regarding Securities)), and the provisions of Article 45 (Miscellaneous Provisions) of that Act (excluding items (iii) and (iv)) shall apply mutatis mutandis to acceptance by a Trust Company of a trust under a trust agreement (meaning those that are specified by a Cabinet Office Ordinance as trust agreements with the risk of a trust principal loss caused by fluctuation in the interest rate, currency value, quotations on a Financial Instruments Market (meaning a Financial Instruments Market as prescribed in Article 2(14) of that Act), or any other index; hereinafter referred to as a "Specific Trust Agreement"). In this case, the term "Contract for a Financial Instruments Transaction" and "Financial Instruments Business" in these provisions shall respectively be deemed to be replaced with "Specific Trust Agreement" and "business for the conclusion of Specific Trust Agreements"; the term "Financial Instruments Transaction" in these provisions (excluding Article 34 of that Act) shall be deemed to be replaced with "conclusion of Specific Trust Agreements"; the term "contract to carry out Acts for a Financial Instruments Transaction (meaning acts listed in the items of Article 2(8); the same shall apply hereinafter) with a customer as the other party or on behalf of a customer" in Article 34 of that Act shall be deemed to be replaced with "Specific Trust Agreements prescribed in Article 24-2 of the Trust Business Act"; the term "the trade name or name and address" in Article 37-3(1)(i) of the Financial Instruments and Exchange Act shall be deemed to be replaced with "the address"; the term "Article 37-4(1)" in Article 37-6(1) of that Act shall be deemed to be replaced with "Article 26(1) of the Trust Business Act"; the terms "Sales and Purchases or Other Transactions of Securities, etc." and "item (i) of the preceding paragraph" in Article 39(2)(i) of the Financial Instruments and Exchange Act shall respectively be deemed to be replaced with "conclusion of Specific Trust Agreements" and "Compensation of Losses, etc. (meaning compensation for losses or supplementation of profit as prescribed in Article 24(1)(iv) of the Trust Business Act; the same shall apply in item (iii))"; the term "Sales and Purchases or Other Transactions of Securities, etc." and "provided under item (iii) of the preceding paragraph" in Article 39(2)(iii) of the Financial Instruments and Exchange Act shall respectively be deemed to be replaced with "conclusion of Specific Trust Agreements" and "pertaining to compensation of losses, etc."; and the term "Problematic Conduct" in Article 39(4) of that Act shall be deemed to be replaced with "an accident imputable to a Trust Company." In addition, the necessary technical replacement of terms shall be specified by a Cabinet Order. 例文帳に追加

第二十四条の二　金融商品取引法第三章第一節第五款（第三十四条の二第六項から第八項まで（特定投資家が特定投資家以外の顧客とみなされる場合）並びに第三十四条の三第五項及び第六項（特定投資家以外の顧客である法人が特定投資家とみなされる場合）を除く。）（特定投資家）、同章第二節第一款（第三十五条から第三十六条の四まで（第一種金融商品取引業又は投資運用業を行う者の業務の範囲、第二種金融商品取引業又は投資助言・代理業のみを行う者の兼業の範囲、顧客に対する誠実義務、標識の掲示、名義貸しの禁止、社債の管理の禁止等）、第三十七条第一項第二号（広告等の規制）、第三十七条の二（取引態様の事前明示義務）、第三十七条の三第一項第二号から第四号まで及び第六号並びに第三項（契約締結前の書面の交付）、第三十七条の四（契約締結時等の書面の交付）、第三十七条の五（保証金の受領に係る書面の交付）、第三十八条第一号及び第二号並びに第三十八条の二（禁止行為）、第三十九条第一項、第二項第二号、第三項及び第五項（損失補てん等の禁止）、第四十条第一号（適合性の原則等）並びに第四十条の二から第四十条の五まで（最良執行方針等、分別管理が確保されていない場合の売買等の禁止、特定投資家向け有価証券の売買等の制限、特定投資家向け有価証券に関する告知義務）を除く。）（通則）及び第四十五条（第三号及び第四号を除く。）（雑則）の規定は、信託会社が行う信託契約（金利、通貨の価格、金融商品市場（同法第二条第十四項に規定する金融商品市場をいう。）における相場その他の指標に係る変動により信託の元本について損失が生ずるおそれがある信託契約として内閣府令で定めるものをいう。以下「特定信託契約」という。）による信託の引受けについて準用する。この場合において、これらの規定中「金融商品取引契約」とあるのは「特定信託契約」と、「金融商品取引業」とあるのは「特定信託契約の締結の業務」と、これらの規定（同法第三十四条の規定を除く。）中「金融商品取引行為」とあるのは「特定信託契約の締結」と、同法第三十四条中「顧客を相手方とし、又は顧客のために金融商品取引行為（第二条第八項各号に掲げる行為をいう。以下同じ。）を行うことを内容とする契約」とあるのは「信託業法第二十四条の二に規定する特定信託契約」と、同法第三十七条の三第一項第一号中「商号、名称又は氏名及び住所」とあるのは「住所」と、同法第三十七条の六第一項中「第三十七条の四第一項」とあるのは「信託業法第二十六条第一項」と、同法第三十九条第二項第一号中「有価証券売買取引等」とあるのは「特定信託契約の締結」と、「前項第一号」とあるのは「損失補てん等（信託業法第二十四条第一項第四号の損失の補てん又は利益の補足をいう。第三号において同じ。）」と、同項第三号中「有価証券売買取引等」とあるのは「特定信託契約の締結」と、「前項第三号の提供」とあるのは「損失補てん等」と、同条第四項中「事故」とあるのは「信託会社の責めに帰すべき事故」と読み替えるものとするほか、必要な技術的読替えは、政令で定める。 - 日本法令外国語訳データベースシステム

Article 13-4 The provisions of Subsection 5 of Section 1 of Chapter III of the Financial Instruments and Exchange Act (excluding Article 34-2(6) to (8) inclusive (Cases Where a Professional Investor Will be Deemed to be a Customer Other than Professional Investor) and Article 34-3(5) and (6) inclusive (Cases Where a Juridical Person who Is a Customer Other Than Professional Investor Will Be Deemed to Be a Professional Investor)) (Professional Investors), Subsection 1 of Section 2 of that Chapter (excluding Articles 35 to 36-4 inclusive (' Scope of Businesses of Persons Who Engage in Type I Financial Instruments Business or Investment Management Business, Scope of Subsidiary Businesses of Persons Who Only Engage in Type II Financial Instruments Business or Investment Advisory and Agency Business, Duty of Good Faith to Customers, Posting of Signs, Prohibition of Name Lending, and Prohibition of Administration of Bonds), Article 37(1)(ii) (Regulation of Advertising, etc.), Article 37-2 (Obligation to Clarify Conditions of Transactions in Advance), Article 37-3(1)(ii) and (vi) and Article 37-3(3) (Delivery of Document Prior to Conclusion of Contract), Article 37-5 (Delivery of Document Pertaining to Receipt of Security Deposit), Article 38(i) and (ii) and Article 38-2 (Prohibited Acts), the proviso to Article 39(3) and Article 39(5) (Prohibition of Compensation of Loss, etc.), Article 40-2 (Best Execution Policy) and Article 40-3 (Prohibition of Sales and Purchase, etc. Where Separate Management Is not Ensured)) (General Rules) and Article 45 (excluding items (iii) and (iv)) (Miscellaneous Provisions) shall apply mutatis mutandis to conclusion of Contracts for Specified Deposits, etc. (meaning contracts on acceptance of Specified Deposits, etc. (meaning those that are specified by a Cabinet Office Ordinance as deposits or Installment Savings, etc. with the risk of a principal loss caused by fluctuations pertaining to the interest rate, currency value, quotations on a financial instruments market prescribed in Article 2(14) of that Act, or any other index); the same shall apply hereinafter) by a Bank. In this case, the term "Contract for Financial Instruments Transaction" in these provisions shall be deemed to be replaced with "Contract for a Specified Deposit, etc.,"; the term "Financial Instruments Business" shall be deemed to be replaced with "Business of Concluding Contracts for Specified Deposits, etc.,"; the term "Act of Financial Instruments Transaction" in these provisions (excluding the provisions in Article 34 of that Act) shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc.,"; the phrase "contract to conduct Acts of Financial Instruments Transaction (meaning acts listed in each item of Article 2(8); the same shall apply hereinafter) with a customer as the other party or on behalf of a customer" in Article 34 of that Act shall be deemed to be replaced with "Contracts for Specified Deposits, etc. as Prescribed in Article 13-4 of the Banking Act,"; the phrase "; provided" in Article 37-3(1) of that Act shall be deemed to be replaced with "and shall, in order to contribute to the protection of Depositors, etc. (meaning Depositors, etc. prescribed in Article 2(5) of the Banking Act; hereinafter the same shall apply in this paragraph), provide the customer in advance with information on the contents of the Contract for a Specified Deposit, etc. and other information that would be helpful for the Depositors, etc., pursuant to the provisions of a Cabinet Office Ordinance; provided,"; the phrase "sales and purchase and any other transaction of Securities (excluding sales and purchase on condition of repurchase for which the repurchase price is set in advance and other transactions specified by a Cabinet Order) or of Derivative Transactions (hereinafter referred to as "Sales and Purchase or Other Transaction of Securities, etc." in this Article)" in Article 39(1)(i) of that Act shall be deemed to be replaced with "conclusion of Contracts for Specified Deposits, etc.,"; the phrase "Securities or Derivative Transactions (hereinafter referred to as "Securities, etc." in this Article)" in that item shall be deemed to be replaced with "Contracts for Specified Deposits, etc.,"; the phrase "customer (in the case where a Trust Company, etc. (meaning a trust company or financial institution that has obtained authorization under Article 1(1) of the Act on Provision, etc. of Trust Business by Financial Institutions; the same shall apply hereinafter) conducts sales and purchase of Securities or Derivative Transactions for the account of the person who sets a trust under a trust contract, including that person who sets the trust; hereinafter the same shall apply in this Article)" in that item shall be deemed to be replaced with "Customers,"; the phrase "make up for" in that item shall be deemed to be replaced with "make up, outside that Contract for a Specified Deposit, etc., for,"; the term "Sales and Purchase or Other Transaction of Securities, etc." in items (ii) and (iii) of that paragraph shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc.,"; the term "Securities, etc." in those items shall be deemed to be replaced with "Contracts for Specified Deposits, etc.,"; the phrase "make an addition to" in item (ii) of that paragraph shall be deemed to be replaced with "make an addition, outside that Contract for a Specified Deposit, etc., to,"; the term "make an addition to" in item (iii) of that paragraph shall be deemed to be replaced with "make an addition, outside that Contract for a Specified Deposit, etc., to,"; the term "Sales and Purchase or Other Transaction of Securities, etc." in paragraph (2) of that Article shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc.,"; the phrase "that is specified by a Cabinet Office Ordinance as a potential cause of" in paragraph (3) of that Article shall be deemed to be replaced with "that is a potential cause of,"; the phrase "Articles 37-2 to 37-6 inclusive, Article 40-2(4), and Article 43-4" in Article 45(ii) of that Act shall be deemed to be replaced with "Article 37-3 (limited to the part pertaining to delivery of a document set forth in paragraph (1) and excluding items (ii) and (vi) of that paragraph and paragraph (3)), Article 37-4 and Article 37-6,"; and any other necessary technical replacement of terms shall be specified by a Cabinet Order. 例文帳に追加

第十三条の四　金融商品取引法第三章第一節第五款（第三十四条の二第六項から第八項まで（特定投資家が特定投資家以外の顧客とみなされる場合）並びに第三十四条の三第五項及び第六項（特定投資家以外の顧客である法人が特定投資家とみなされる場合）を除く。）（特定投資家）、同章第二節第一款（第三十五条から第三十六条の四まで（第一種金融商品取引業又は投資運用業を行う者の業務の範囲、第二種金融商品取引業又は投資助言・代理業のみを行う者の兼業の範囲、顧客に対する誠実義務、標識の掲示、名義貸しの禁止及び社債の管理の禁止等）、第三十七条第一項第二号（広告等の規制）、第三十七条の二（取引態様の事前明示義務）、第三十七条の三第一項第二号及び第六号並びに第三項（契約締結前の書面の交付）、第三十七条の五（保証金の受領に係る書面の交付）、第三十八条第一号及び第二号並びに第三十八条の二（禁止行為）、第三十九条第三項ただし書及び第五項（損失補てん等の禁止）、第四十条の二（最良執行方針等）並びに第四十条の三（分別管理が確保されていない場合の売買等の禁止）を除く。）（通則）及び第四十五条（第三号及び第四号を除く。）（雑則）の規定は、銀行が行う特定預金等契約（特定預金等（金利、通貨の価格、同法第二条第十四項に規定する金融商品市場における相場その他の指標に係る変動によりその元本について損失が生ずるおそれがある預金又は定期積金等として内閣府令で定めるものをいう。）の受入れを内容とする契約をいう。以下同じ。）の締結について準用する。この場合において、これらの規定中「金融商品取引契約」とあるのは「特定預金等契約」と、「金融商品取引業」とあるのは「特定預金等契約の締結の業務」と、これらの規定（同法第三十四条の規定を除く。）中「金融商品取引行為」とあるのは「特定預金等契約の締結」と、同法第三十四条中「顧客を相手方とし、又は顧客のために金融商品取引行為（第二条第八項各号に掲げる行為をいう。以下同じ。）を行うことを内容とする契約」とあるのは「銀行法第十三条の四に規定する特定預金等契約」と、同法第三十七条の三第一項中「交付しなければならない」とあるのは「交付するほか、預金者等（銀行法第二条第五項に規定する預金者等をいう。以下この項において同じ。）の保護に資するため、内閣府令で定めるところにより、当該特定預金等契約の内容その他預金者等に参考となるべき情報の提供を行わなければならない」と、同法第三十九条第一項第一号中「有価証券の売買その他の取引（買戻価格があらかじめ定められている買戻条件付売買その他の政令で定める取引を除く。）又はデリバティブ取引（以下この条において「有価証券売買取引等」という。）」とあるのは「特定預金等契約の締結」と、「有価証券又はデリバティブ取引（以下この条において「有価証券等」という。）」とあるのは「特定預金等契約」と、「顧客（信託会社等（信託会社又は金融機関の信託業務の兼営等に関する法律第一条第一項の認可を受けた金融機関をいう。以下同じ。）が、信託契約に基づいて信託をする者の計算において、有価証券の売買又はデリバティブ取引を行う場合にあつては、当該信託をする者を含む。以下この条において同じ。）」とあるのは「顧客」と、「補足するため」とあるのは「補足するため、当該特定預金等契約によらないで」と、同項第二号及び第三号中「有価証券売買取引等」とあるのは「特定預金等契約の締結」と、「有価証券等」とあるのは「特定預金等契約」と、同項第二号中「追加するため」とあるのは「追加するため、当該特定預金等契約によらないで」と、同項第三号中「追加するため、」とあるのは「追加するため、当該特定預金等契約によらないで」と、同条第二項中「有価証券売買取引等」とあるのは「特定預金等契約の締結」と、同条第三項中「原因となるものとして内閣府令で定めるもの」とあるのは「原因となるもの」と、同法第四十五条第二号中「第三十七条の二から第三十七条の六まで、第四十条の二第四項及び第四十三条の四」とあるのは「第三十七条の三（第一項の書面の交付に係る部分に限り、同項第二号及び第六号並びに第三項を除く。）、第三十七条の四及び第三十七条の六」と読み替えるものとするほか、必要な技術的読替えは、政令で定める。 - 日本法令外国語訳データベースシステム

Article 13-4 The provisions of Chapter III, Section 1, Subsection 5 of the Financial Instruments and Exchange Act (excluding Article 34-2, paragraphs (6) to (8) inclusive (Cases Where a Professional Investor Will Be Deemed to Be a Customer Other than Professional Investor) and Article 34-3, paragraphs (5) and (6) inclusive (Cases Where a Juridical Person Who Is a Customer Other Than a Professional Investor Will Be Deemed to Be a Professional Investor)) (Professional Investors), Section 2, Subsection 1 of that Chapter (excluding Articles 35 to 36-4 inclusive (Scope of Business Activities of Persons Who Engage in Type I Financial Instruments Services or Investment Management, Scope of Concurrent Business Activities of Persons Who Only Engage in Type II Financial Instruments Services or Investment Advisory and Agency Services, Duty of Good Faith to Customers, Posting of Signs, Prohibition on Name Lending, Prohibition on Administration of Corporate Bonds), Article 37, paragraph (1), item (ii) (Regulations on Advertising, etc.), Article 37-2 (Obligation to Clarify Conditions of Transactions in Advance), Article 37-3, paragraph (1), items (ii) and (vi) and Article 37-3, paragraph (3) (Delivery of Documents Prior to the Conclusion of a Contract), Article 37-5 (Delivery of Documents Pertaining to the Receipt of Security Deposits), Article 37-7 (Obligation to Conclude a Contract, etc. with a Designated Dispute Resolution Organization), Article 38, items (i) and (ii) and Article 38-2 (Prohibited Acts), the proviso to Article 39, paragraph (3) and Article 39, paragraph (5) (Prohibition of Compensation of Loss, etc.) and Articles 40-2 to 40-5 inclusive (Best Execution Policy, Prohibition on Purchase and Sale, etc. Where Separate Management Is not Ensured, Limitation on the Purchase and Sale, etc. of Securities for Professional Investors, Obligation of Notification in Relation to Securities for Professional Investors)) (General Rules) and Article 45 (excluding items (iii) and (iv)) (Miscellaneous Provisions) of the Financial Instruments and Exchange Act shall apply mutatis mutandis to the conclusion of Contracts for Specified Deposits, etc. (meaning contracts on acceptance of Specified Deposits, etc. (meaning those that are specified by Cabinet Office Ordinance as deposits or Installment Savings, etc. with the risk of a principal loss caused by fluctuations pertaining to the interest rate, currency value, quotations on a financial instruments market prescribed in Article 2, paragraph (14) of that Act, or any other index); the same shall apply hereinafter) by a Bank. In this case, the term "Contract for a Financial Instruments Transaction" in these provisions shall be deemed to be replaced with "Contract for a Specified Deposit, etc."; the term "Financial Instruments Services" in these provisions shall be deemed to be replaced with "Concluding Contracts for Specified Deposits, etc."; the term "Act of Executing a Financial Instruments Transaction" in these provisions (excluding the provisions of Article 34 of that Act) shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc."; the phrase "contract to conduct the Act of Financial Instruments Transactions (meaning an act listed in the items of Article 2, paragraph (8); the same shall apply hereinafter) with a customer as the other party or on behalf of a customer" in Article 34 of that Act shall be deemed to be replaced with "Contracts for Specified Deposits, etc. as Prescribed in Article 13-4 of the Banking Act"; the phrase "; provided" in Article 37-3, paragraph (1) of that Act shall be deemed to be replaced with "and shall, in order to contribute to the protection of Depositors, etc. (meaning Depositors, etc. prescribed in Article 2, paragraph (5) of the Banking Act; hereinafter the same shall apply in this paragraph), provide the customer with information on the contents of the Contract for a Specified Deposit, etc. and other information that would be helpful for the Depositors, etc. in advance, pursuant to the provisions of Cabinet Office Ordinance; provided"; the phrase "purchase and sale or other transaction of Securities (excluding a purchase and sale on condition of repurchase for which the repurchase price is set in advance and other transactions specified by Cabinet Order) or Derivative Transactions (hereinafter referred to as the "Purchase and Sale or Other Transaction of Securities, etc." in this Article)" in Article 39, paragraph (1), item (i) of that Act shall be deemed to be replaced with "conclusion of Contracts for Specified Deposits, etc."; the phrase "Securities or Derivative Transactions (hereinafter collectively referred to as "Securities, etc." in this Article)" in that item shall be deemed to be replaced with "Contracts for Specified Deposits, etc."; the phrase "customer (in cases where a Trust Company, etc. (meaning a trust company or financial institution that has obtained authorization under Article 1, paragraph (1) of the Act on Engagement in Trust Business by a Financial Institution; the same shall apply hereinafter) conducts the purchase and sale of Securities or Derivative Transactions on the account of the person who establishes a trust under a trust contract, including such person who establishes the trust; hereinafter the same shall apply in this Article)" in that item shall be deemed to be replaced with "Customers"; the phrase "make up for" in that item shall be deemed to be replaced with "make up for, outside that Contract for a Specified Deposit, etc."; the term "Purchase and Sale or Other Transaction of Securities, etc." in Article 39, paragraph (1), items (ii) and (iii) of that Act shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc."; the term "Securities, etc." in those items shall be deemed to be replaced with "Contracts for Specified Deposits, etc."; the phrase "make an addition to" in item (ii) of that paragraph shall be deemed to be replaced with "make an addition to, outside that Contract for a Specified Deposit, etc."; the term "make an addition to" in item (iii) of that paragraph shall be deemed to be replaced with "make an addition to, outside that Contract for a Specified Deposit, etc."; the term "Purchase and Sale or Other Transaction of Securities, etc." in paragraph (2) of that Article shall be deemed to be replaced with "Conclusion of Contracts for Specified Deposits, etc."; the phrase "that is specified by Cabinet Office Ordinance as a potential cause of" in paragraph (3) of that Article shall be deemed to be replaced with "that may be a potential cause of"; the phrase "Articles 37-2 to 37-6 inclusive, Article 40-2, paragraph (4), and Article 43-4" in Article 45, item (ii) of that Act shall be deemed to be replaced with "Article 37-3 (limited to the part pertaining to delivery of a document set forth in paragraph (1) and excluding items (ii) and (vi) of that paragraph and paragraph (3)), Article 37-4 and Article 37-6"; and any other necessary technical replacement of terms shall be specified by a Cabinet Order. 例文帳に追加

第十三条の四　金融商品取引法第三章第一節第五款（第三十四条の二第六項から第八項まで（特定投資家が特定投資家以外の顧客とみなされる場合）並びに第三十四条の三第五項及び第六項（特定投資家以外の顧客である法人が特定投資家とみなされる場合）を除く。）（特定投資家）、同章第二節第一款（第三十五条から第三十六条の四まで（第一種金融商品取引業又は投資運用業を行う者の業務の範囲、第二種金融商品取引業又は投資助言・代理業のみを行う者の兼業の範囲、顧客に対する誠実義務、標識の掲示、名義貸しの禁止、社債の管理の禁止等）、第三十七条第一項第二号（広告等の規制）、第三十七条の二（取引態様の事前明示義務）、第三十七条の三第一項第二号及び第六号並びに第三項（契約締結前の書面の交付）、第三十七条の五（保証金の受領に係る書面の交付）、第三十七条の七（指定紛争解決機関との契約締結義務等）、第三十八条第一号及び第二号並びに第三十八条の二（禁止行為）、第三十九条第三項ただし書及び第五項（損失補てん等の禁止）並びに第四十条の二から第四十条の五まで（最良執行方針等、分別管理が確保されていない場合の売買等の禁止、特定投資家向け有価証券の売買等の制限、特定投資家向け有価証券に関する告知義務）を除く。）（通則）及び第四十五条（第三号及び第四号を除く。）（雑則）の規定は、銀行が行う特定預金等契約（特定預金等（金利、通貨の価格、同法第二条第十四項に規定する金融商品市場における相場その他の指標に係る変動によりその元本について損失が生ずるおそれがある預金又は定期積金等として内閣府令で定めるものをいう。）の受入れを内容とする契約をいう。以下同じ。）の締結について準用する。この場合において、これらの規定中「金融商品取引契約」とあるのは「特定預金等契約」と、「金融商品取引業」とあるのは「特定預金等契約の締結の業務」と、これらの規定（同法第三十四条の規定を除く。）中「金融商品取引行為」とあるのは「特定預金等契約の締結」と、同法第三十四条中「顧客を相手方とし、又は顧客のために金融商品取引行為（第二条第八項各号に掲げる行為をいう。以下同じ。）を行うことを内容とする契約」とあるのは「銀行法第十三条の四に規定する特定預金等契約」と、同法第三十七条の三第一項中「交付しなければならない」とあるのは「交付するほか、預金者等（銀行法第二条第五項に規定する預金者等をいう。以下この項において同じ。）の保護に資するため、内閣府令で定めるところにより、当該特定預金等契約の内容その他預金者等に参考となるべき情報の提供を行わなければならない」と、同法第三十九条第一項第一号中「有価証券の売買その他の取引（買戻価格があらかじめ定められている買戻条件付売買その他の政令で定める取引を除く。）又はデリバティブ取引（以下この条において「有価証券売買取引等」という。）」とあるのは「特定預金等契約の締結」と、「有価証券又はデリバティブ取引（以下この条において「有価証券等」という。）」とあるのは「特定預金等契約」と、「顧客（信託会社等（信託会社又は金融機関の信託業務の兼営等に関する法律第一条第一項の認可を受けた金融機関をいう。以下同じ。）が、信託契約に基づいて信託をする者の計算において、有価証券の売買又はデリバティブ取引を行う場合にあつては、当該信託をする者を含む。以下この条において同じ。）」とあるのは「顧客」と、「補足するため」とあるのは「補足するため、当該特定預金等契約によらないで」と、同項第二号及び第三号中「有価証券売買取引等」とあるのは「特定預金等契約の締結」と、「有価証券等」とあるのは「特定預金等契約」と、同項第二号中「追加するため」とあるのは「追加するため、当該特定預金等契約によらないで」と、同項第三号中「追加するため、」とあるのは「追加するため、当該特定預金等契約によらないで」と、同条第二項中「有価証券売買取引等」とあるのは「特定預金等契約の締結」と、同条第三項中「原因となるものとして内閣府令で定めるもの」とあるのは「原因となるもの」と、同法第四十五条第二号中「第三十七条の二から第三十七条の六まで、第四十条の二第四項及び第四十三条の四」とあるのは「第三十七条の三（第一項の書面の交付に係る部分に限り、同項第二号及び第六号並びに第三項を除く。）、第三十七条の四及び第三十七条の六」と読み替えるものとするほか、必要な技術的読替えは、政令で定める。 - 日本法令外国語訳データベースシステム